CLINICAL_TRIALS
trial_result
· 2021-09-21
Clinical Trial Update: Hydrocortisone for COVID-19 and Severe Hypoxia [Phase 3]
Summary
A Phase 3 trial evaluating hydrocortisone for COVID-19 with severe hypoxia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Scandinavian Critical Care Trials Group | Conditions: Covid-19, Hypoxia | Phase 3 | Status: COMPLETED